Disclaimer: I receive no compensation for any products or services that I recommend.
One of the challenges in integrating neurophysiology with Traditional Chinese Medicine (TCM) to address patterns of spasticity is the need to translate qualitative TCM concepts (pattern differentiation) into a concrete clinical treatment. In my prior work in clinical toxicology, there was rigorous attention to method development that was objective and could hold up in a court of law. This involved testing using spikes, controls, and repeated analysis to ensure accuracy and reliability. The challenge now lies in how to use TCM, which employs more qualitative methods, to create objective treatments for various patterns successfully. This approach is particularly important in the treatment of neurogenic diseases, where our understanding of pathology is in its infancy. The pharmaceutical industry, which is supposed to adhere to similar rigorous standards, is falling increasingly short.